Spatially encoded biological assays

Patent metadata

Field	Value
Publication number	US-10662468-B2
Application number	US-201916660234-A
Country	US
Kind code	B2
Filing date	Oct 22, 2019
Priority date	Apr 5, 2010
Publication date	May 26, 2020
Grant date	May 26, 2020

Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

First claim

The invention claimed is:

1. A method for determining the presence or abundance of a nucleic acid at a location in a tissue section comprising:
(a) contacting the tissue section with an array comprising a plurality of features, wherein a feature of the plurality of features comprises a capture agent, wherein the capture agent comprises:
(i) a first sequence that specifically binds the nucleic acid, and
(ii) a second sequence comprising a coding tag, wherein a sequence of the coding tag corresponds to a location of the capture agent on the array;

(b) determining all or a portion of the sequence of the coding tag, or a complement thereof, and all or a portion of the sequence of the nucleic acid specifically bound to the capture agent, or a complement thereof, and using the determined sequences to determine presence or abundance of the nucleic acid at a location in the tissue section.

2. The method of claim 1 , wherein the method further comprises, between steps (a) and (b), a step of removing the tissue section from the array.

3. The method of claim 2 , wherein the removing step includes the use of an RNase.

4. The method of claim 2 , wherein the removing step includes washing the array to remove any nucleic acid(s) not specifically bound to the capture agent.

5. The method of claim 1 , wherein the capture agent, when specifically bound to the nucleic acid, can function as a primer.

6. The method of claim 1 , wherein the determining step comprises nucleic acid amplification.

7. The method of claim 1 , wherein the determining step comprises sequencing all or a portion of the sequence of the coding tag, or a complement thereof, and all or a portion of the sequence of the nucleic acid specifically bound to the capture agent, or a complement thereof.

8. The method of claim 1 , wherein the capture agent further comprises one or both of a primer region and an adaptor region.

9. The method of claim 8 , wherein one or both of the primer region and the adaptor region comprise(s) a universal nucleotide sequence.

10. The method of claim 1 , wherein the nucleic acid is DNA.

11. The method of claim 10 , wherein the DNA is genomic DNA.

12. The method of claim 1 , wherein the nucleic acid is RNA.

13. The method of claim 12 , wherein the RNA is mRNA.

14. The method of claim 13 , wherein the determining step includes generation of a cDNA using the capture agent specifically bound to the nucleic acid as a primer.

15. The method of claim 14 , wherein the generated cDNA comprises all or a portion of the sequence of the coding tag, and a sequence complementary to all or a portion of the sequence of the nucleic acid.

16. The method of claim 14 , wherein the determining step further comprises amplifying the cDNA.

17. The method of claim 1 , wherein the feature of the plurality of features comprises a bead, well, or channel.

18. The method of claim 1 , wherein the capture agent is immobilized directly or indirectly on a surface of the feature.

19. The method of claim 1 , wherein the array comprises a nucleic acid array.

20. The method of claim 1 , wherein the array comprises a bead array.

21. The method of claim 1 , wherein the tissue section is a fresh frozen tissue section or a formalin-fixed paraffin-embedded (FFPE) tissue section.

22. The method of claim 1 , wherein the method further comprises imaging the tissue section contacted with the array.

23. The method of claim 1 , wherein the method further comprises generating a map of the presence or abundance of the nucleic acid at location(s) in the tissue section.

24. The method of claim 1 , wherein the tissue section comprises tissue from a subject, and the method further comprises performing steps (a) and (b) on additional, serial tissue section(s) obtained from the subject.

25. The method of claim 1 , wherein the array comprises greater than 500 features.

26. The method of claim 1 , wherein the array comprises greater than 1,000 features.

27. The method of claim 1 , wherein the array comprises greater than 10,000 features.

28. The method of claim 1 , wherein a feature of the plurality of features comprises greater than 20 capture agents, where each of the greater than 20 capture agents comprises a first sequence that specifically binds to a different nucleic acid and a coding tag that corresponds to a location of the capture agent on the array.

29. The method of claim 1 , wherein a feature of the plurality of features comprises greater than 50 capture agents, where each of the greater than 50 capture agents comprises a first sequence that specifically binds to a different nucleic acid and a coding tag that corresponds to a location of the capture agent on the array.

30. The method of claim 1 , wherein a feature of the plurality of features comprises greater than 100 capture agents, where each of the greater than 100 capture agents comprises a first sequence that specifically binds to a different nucleic acid and a coding tag that corresponds to a location of the capture agent on the array.

Assignees

• Prognosys Biosciences Inc

Inventors

• Chee Mark S

Classifications

• C12Q1/6869

  Methods for sequencing · CPC title

• C12Q1/6809 Primary

  Methods for determination or identification of nucleic acids involving differential detection · CPC title

• C12Q1/6876

  Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

• G01N33/6845

  Methods of identifying protein-protein interactions in protein mixtures · CPC title

• C40B30/04

  by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding · CPC title